Singular Genomics to Report Second Quarter 2024 Financial Results on August 13, 2024

Company Overview - Singular Genomics is a life science technology company focused on developing next-generation sequencing and multiomics technologies [2] - The G4® Sequencing Platform is a benchtop genomic sequencer that delivers fast and accurate results [2] - The company is also developing the G4X™ Spatial Sequencer, which will utilize proprietary sequencing technology for in situ readouts in various biological contexts [2] Financial Reporting - Singular Genomics will report its financial results for the second quarter ended June 30, 2024, after market close on August 13, 2024 [3] - A conference call to discuss the financial results will take place at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time [3]